Specialty Drug Manufacturer Assistance Programs And Your Plan by Sarah Martin, ASA, MAAA, FCA, CEBS, Vice President Manufacturer assistance, also known as patient assistance programs, copay
Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER released an Evidence Report assessing the
Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap that is a little longer than usual
Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: On Wednesday, ICER released its Draft Evidence
Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER published its evidence report assessing the
Psychosocial Barriers Affecting Medication Adherence; the Importance of the Provider/Patient Relationship by Clay Keene, Vice President Medication adherence represents an ongoing clinical and financial challenge within
As you may recall, back in March of this year, Eli Lilly announced that they would begin to manufacture and sell an authorized generic version
Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: As we step one week closer to
Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER published its revised Evidence Report assessing
Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: This week ICER announced the beginning of
© Copyright 2019 Excelsior Solutions • Privacy Policy • All Rights Reserved